thiazoles has been researched along with rolipram in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barron, E; Bruin, J; de Boer, J; Dent, G; Kelly, JJ; Nicholson, CD; Shahid, M; Spiers, I; van Amsterdam, RG; Zaagsma, J | 1 |
Barnes, PJ; Chung, KF; Elwood, W; Giembycz, MA; Sun, J | 1 |
Breton, J; Griswold, DE; Marshall, PJ; Torphy, TJ; Webb, EF; White, JR | 1 |
Meurs, H; Olymulder, CG; Santing, RE; Van der Molen, K; Zaagsma, J | 1 |
Carlson, RP; Hartman, DA; Ochalski, SJ | 1 |
Barnes, PJ; Giembycz, MA; Kelly, JJ | 1 |
Drakulic, D; Miljkovic, Dj; Samardzic, T; Stosic-Grujicic, S; Trajkovic, V | 1 |
Baldi, A; Bianciotti, LG; Copsel, S; Davio, C; Diez, F; Garcia, C; Russel, FG; Shayo, C; Vermeulem, M | 1 |
Arban, R; Cavallini, P; Davies, CH; Davis, TG; Gray, FA; Montanari, D; Negri, M; Poffe, A; Rutter, AR; Schneck, J; Vicentini, E; Wren, PB | 1 |
9 other study(ies) available for thiazoles and rolipram
Article | Year |
---|---|
Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Asthma; Cattle; Guinea Pigs; Humans; In Vitro Techniques; Isoenzymes; Male; Muscle, Smooth, Vascular; Papillary Muscles; Phosphodiesterase Inhibitors; Pyrrolidinones; Rabbits; Rolipram; Thiazoles; Trachea | 1995 |
Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in brown-Norway rats.
Topics: Administration, Inhalation; Aerosols; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Cell Count; Disease Models, Animal; Eosinophils; Female; Injections, Intraperitoneal; Neutrophils; Ovalbumin; Phosphodiesterase Inhibitors; Pulmonary Eosinophilia; Pyrrolidinones; Rats; Rats, Inbred BN; Rolipram; Thiazoles | 1995 |
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Calcimycin; Cells, Cultured; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 4; Ear, External; Eicosanoids; Histamine Release; Humans; Imidazoles; Inflammation; Leukotriene B4; Male; Mast Cells; Mice; Mice, Inbred BALB C; Monocytes; Nadolol; Naproxen; Neutrophils; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrazoles; Pyrrolidinones; Receptors, Adrenergic, beta; Rolipram; SRS-A; Thiazoles | 1993 |
Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Analysis of Variance; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Eosinophils; Guinea Pigs; Histamine; Hypersensitivity; Inflammation; Injections, Intraperitoneal; Isoenzymes; Macrophages; Male; Neutrophils; Ovalbumin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Specific Pathogen-Free Organisms; Theophylline; Thiazoles | 1995 |
The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dexamethasone; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Imidazoles; Interleukin-1; Interleukin-6; Interleukin-8; Leukocytes; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Regression Analysis; Rolipram; Thiazoles; Tumor Necrosis Factor-alpha; Zymosan | 1995 |
Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding Sites; Brain; Chromatography, Ion Exchange; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Isoenzymes; Isoproterenol; Kinetics; Macrophages, Peritoneal; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Quinazolines; Rats; Regression Analysis; Rolipram; Stereoisomerism; Thiazoles; Tritium | 1996 |
Immunosuppressants leflunomide and mycophenolic acid inhibit fibroblast IL-6 production by distinct mechanisms.
Topics: Aniline Compounds; Animals; Cell Line; Cell Survival; Cells, Cultured; Coloring Agents; Crotonates; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Guanidines; Humans; Hydroxybutyrates; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Isoxazoles; Leflunomide; Macrophages; Mice; Mycophenolic Acid; Nitric Oxide Synthase; Nitriles; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Rolipram; Tetrazolium Salts; Thiazoles; Time Factors; Toluidines | 2002 |
Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.
Topics: Cell Differentiation; Cell Division; Cyclic AMP; Drug Design; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Phosphodiesterase 4 Inhibitors; Probenecid; RNA, Small Interfering; Rolipram; Signal Transduction; Thiazoles; U937 Cells | 2011 |
GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Behavior, Animal; Benzamides; Callithrix; Cerebral Cortex; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Drug Evaluation, Preclinical; Ferrets; Inflammation; Isoenzymes; Macaca fascicularis; Male; Nootropic Agents; Oxadiazoles; Phosphodiesterase 4 Inhibitors; Pica; Rats; Rolipram; Thiazoles | 2014 |